Cargando…
SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
Hodgkin lymphoma (HL) is an uncommon B cell lymphoid malignancy representing approximately 10–15 % of all lymphomas. HL is composed of two distinct disease entities; the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. An accurate assessment of the stage of diseas...
Autores principales: | Rueda Domínguez, A., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689754/ https://www.ncbi.nlm.nih.gov/pubmed/26497354 http://dx.doi.org/10.1007/s12094-015-1429-1 |
Ejemplares similares
-
SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
por: Provencio Pulla, M., et al.
Publicado: (2015) -
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
por: Gumà, Josep, et al.
Publicado: (2023) -
SEOM clinical guidelines in metastatic breast cancer 2015
por: Gavilá, J., et al.
Publicado: (2015) -
SEOM clinical guidelines for the management of germ cell testicular cancer (2016)
por: Aparicio, J., et al.
Publicado: (2016) -
SEOM clinical guideline for the management of cutaneous melanoma (2020)
por: Majem, M., et al.
Publicado: (2021)